Rapport Therapeutics, Inc. · NASDAQ:RAPP
Third Rock Ventures V, L.P. reported a 13.10% stake in Rapport Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Third Rock Ventures V, L.P. reported a 13.10% stake in Rapport Therapeutics, Inc., 6,280,525 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 13.10%
- Shares
- 6,280,525
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Third Rock Ventures V, L.P. | 13.10% | 6,280,525 |
| Third Rock Ventures GP V, L.P. | 13.10% | 6,280,525 |
| TRV GP V, LLC | 13.10% | 6,280,525 |
| Third Rock Ventures VI, L.P. | 2.00% | 969,218 |
| Third Rock Ventures GP VI, L.P. | 2.00% | 969,218 |
| TRV GP VI, LLC | 2.00% | 969,218 |
Source
Related
- Rapport Therapeutics, Inc.
- Third Rock Ventures V, L.P.
- Rapport Therapeutics, Inc. shareholders
- Schedule 13G · Third Rock Ventures V, L.P. · Feb 13, 2025
- Form 4 · Ignelzi Troy A. · Oct 21, 2026
- Form 4 · Ceesay Abraham · Oct 8, 2026
- Form 4 · Gault Cheryl · Oct 1, 2026
- Form 4 · Ceesay Abraham · Sep 24, 2026
- Form 4 · Ceesay Abraham · Sep 9, 2026